PortfoliosLab logo
ALGN vs. WST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALGN and WST is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

ALGN vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Align Technology, Inc. (ALGN) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

0.00%2,000.00%4,000.00%6,000.00%8,000.00%NovemberDecember2025FebruaryMarchApril
959.21%
4,622.55%
ALGN
WST

Key characteristics

Sharpe Ratio

ALGN:

-1.01

WST:

-0.82

Sortino Ratio

ALGN:

-1.52

WST:

-0.90

Omega Ratio

ALGN:

0.83

WST:

0.83

Calmar Ratio

ALGN:

-0.51

WST:

-0.76

Martin Ratio

ALGN:

-1.35

WST:

-1.80

Ulcer Index

ALGN:

30.55%

WST:

24.88%

Daily Std Dev

ALGN:

40.81%

WST:

54.63%

Max Drawdown

ALGN:

-92.80%

WST:

-59.29%

Current Drawdown

ALGN:

-74.88%

WST:

-54.13%

Fundamentals

Market Cap

ALGN:

$13.42B

WST:

$15.41B

EPS

ALGN:

$5.62

WST:

$6.37

PE Ratio

ALGN:

32.62

WST:

33.68

PEG Ratio

ALGN:

1.10

WST:

3.59

PS Ratio

ALGN:

3.36

WST:

5.32

PB Ratio

ALGN:

3.50

WST:

5.75

Total Revenue (TTM)

ALGN:

$3.00B

WST:

$2.90B

Gross Profit (TTM)

ALGN:

$2.11B

WST:

$1.00B

EBITDA (TTM)

ALGN:

$633.28M

WST:

$685.60M

Returns By Period

In the year-to-date period, ALGN achieves a -12.07% return, which is significantly higher than WST's -34.46% return. Over the past 10 years, ALGN has underperformed WST with an annualized return of 11.82%, while WST has yielded a comparatively higher 15.03% annualized return.


ALGN

YTD

-12.07%

1M

11.60%

6M

-16.39%

1Y

-40.67%

5Y*

-1.40%

10Y*

11.82%

WST

YTD

-34.46%

1M

-5.09%

6M

-30.23%

1Y

-40.36%

5Y*

1.86%

10Y*

15.03%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALGN vs. WST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALGN
The Risk-Adjusted Performance Rank of ALGN is 1010
Overall Rank
The Sharpe Ratio Rank of ALGN is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of ALGN is 66
Sortino Ratio Rank
The Omega Ratio Rank of ALGN is 99
Omega Ratio Rank
The Calmar Ratio Rank of ALGN is 1919
Calmar Ratio Rank
The Martin Ratio Rank of ALGN is 1414
Martin Ratio Rank

WST
The Risk-Adjusted Performance Rank of WST is 88
Overall Rank
The Sharpe Ratio Rank of WST is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of WST is 1515
Sortino Ratio Rank
The Omega Ratio Rank of WST is 99
Omega Ratio Rank
The Calmar Ratio Rank of WST is 77
Calmar Ratio Rank
The Martin Ratio Rank of WST is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALGN vs. WST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Align Technology, Inc. (ALGN) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for ALGN, currently valued at -1.01, compared to the broader market-2.00-1.000.001.002.003.00
ALGN: -1.01
WST: -0.82
The chart of Sortino ratio for ALGN, currently valued at -1.52, compared to the broader market-6.00-4.00-2.000.002.004.00
ALGN: -1.52
WST: -0.90
The chart of Omega ratio for ALGN, currently valued at 0.83, compared to the broader market0.501.001.502.00
ALGN: 0.83
WST: 0.83
The chart of Calmar ratio for ALGN, currently valued at -0.51, compared to the broader market0.001.002.003.004.005.00
ALGN: -0.51
WST: -0.76
The chart of Martin ratio for ALGN, currently valued at -1.35, compared to the broader market-5.000.005.0010.0015.0020.00
ALGN: -1.35
WST: -1.80

The current ALGN Sharpe Ratio is -1.01, which is comparable to the WST Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of ALGN and WST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.50NovemberDecember2025FebruaryMarchApril
-1.01
-0.82
ALGN
WST

Dividends

ALGN vs. WST - Dividend Comparison

ALGN has not paid dividends to shareholders, while WST's dividend yield for the trailing twelve months is around 0.29%.


TTM20242023202220212020201920182017201620152014
ALGN
Align Technology, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
WST
West Pharmaceutical Services, Inc.
0.29%0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%

Drawdowns

ALGN vs. WST - Drawdown Comparison

The maximum ALGN drawdown since its inception was -92.80%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for ALGN and WST. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%NovemberDecember2025FebruaryMarchApril
-74.88%
-54.13%
ALGN
WST

Volatility

ALGN vs. WST - Volatility Comparison

Align Technology, Inc. (ALGN) has a higher volatility of 18.38% compared to West Pharmaceutical Services, Inc. (WST) at 15.01%. This indicates that ALGN's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%NovemberDecember2025FebruaryMarchApril
18.38%
15.01%
ALGN
WST

Financials

ALGN vs. WST - Financials Comparison

This section allows you to compare key financial metrics between Align Technology, Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items